This is the amplicon context sequence in accordance with the minimum information for the publication of real-time quantitative PCR experiements (MIQE) guidelines. For more details, please refer to the following publication, "Primer Sequence Disclosure: A Clarification of the MIQE Guidelines."
ddPCR™ probe assay designed for mutation detection. Probe assays consist of unlabeled PCR primers and a dual labeled fluorescent probe.
Info: 65nt amplicon; crosses exon-intron junction; in silico
This gene encodes a receptor tyrosine kinase which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain an hydrophobic stretch corresponding to a single pass transmembrane region and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged mutated or amplified in a series of tumours including anaplastic large cell lymphomas neuroblastoma and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene which result in creation of multiple fusion genes in tumourigenesis including ALK (chromosome 2)/EML4 (chromosome 2) ALK/RANBP2 (chromosome 2) ALK/ATIC (chromosome 2) ALK/TFG (chromosome 3) ALK/NPM1 (chromosome 5) ALK/SQSTM1 (chromosome 5) ALK/KIF5B (chromosome 10) ALK/CLTC (chromosome 17) ALK/TPM4 (chromosome 19) and ALK/MSN (chromosome X).[provided by RefSeq Jan 2011]